MC044h, a phase II trial of sorafenib in patients (pts) with metastatic neuroendocrine tumors (NET): a Phase II Consortium (P2C) study

Authors
Category Primary study
Year 2007
This article has no abstract
Epistemonikos ID: 3611c4ce50ecdc36fe3104bcd5082fe300ce32d9
First added on: Jul 22, 2020